| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.18 | 0.0007 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0007 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |